
Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.


Building Relationships vs. Publishing Content: Reflecting on the Renewed Interest In Migraine Disease
A new class of migraine drugs, called anti-CGRPs (calcitonin gene-related peptide) are expected to reinvigorate a market that has been largely dormant for some time. Four biopharma companies, Amgen, Teva, Lilly and Alder are entering the fray. Not surprisingly, the intense competition and pharma investment associated with this market dynamic has led traditional “eyeball driven” publishers, like WebMD, Everyday Health and others on a quest to offer substantially more migraine-related content in reaction to this market opportunity.

What People Fear the Most About Their Future With Asthma
"Asthma In America 2018" asked questions about diagnosis, medications, treatments and more to over 800 respondents. Surprisingly, the survey revealed four things people with asthma fear most about their future, all of which have a profound impact on the way they view their condition and rate their quality of life.

The High Cost of Living with Inflammatory Bowel Disease
IBD In America 2018, a recent survey conducted by Health Union, revealed that 41% of people with inflammatory bowel disease (IBD) say their household finances are significantly impacted by the out-of-pocket costs associated with their condition.
Get Hooked – Making Engagement a Habit
This month, Amrita continues her series in DTC Perspectives monthly e-newsletter, DTC In Focus by discussing how to get patients hooked on engagement.
Cultivating Engaged Patients: 5 Lessons Learned
Discover valuable lessons and practical tips to stimulate and cultivate patient engagement for active online health communities.
Contact
1218 Chestnut St., 3rd Floor
Philadelphia, PA 19107
Phone: 484-985-9715
Fax: 484-450-2513
Privacy Policy
Terms of Use
Your Privacy Choices
Join Our Team
Press Kit